- U.S. stock futures showed mixed results during Wednesday's pre-market session as multiple major companies experienced significant share price declines.
- Intuit shares dropped 11.7% to $315.50 after issuing fiscal year 2027 guidance that fell below analyst expectations despite reporting upbeat fourth-quarter revenue of $4.35 billion and adjusted earnings of $4.03 per share.
- Other notable stocks moving lower included Zoom Communications, which fell 5.8% due to soft third-quarter guidance, alongside Qfin Holdings and Spyre Therapeutics following unfavorable financial and clinical trial updates.
- Intuit shares fell 9.8% after projecting slower sales growth and potential short-term trade-offs to boost TurboTax customers.
- Spyre Therapeutics stock slid 11% following trial results that caused the company to deprioritize a rheumatoid arthritis drug candidate.
- Zoom Communications and nCino both experienced stock declines after issuing third-quarter financial guidance that missed Wall Street expectations.
